Serum 25-hydroxyvitamin D levels are not associated with adverse outcomes in Clostridium difficile infection

• Päätekijät: Dejan Micic (Tekijä), Krishna Rao (Tekijä), Bruno Caetano Trindade (Tekijä), Seth T. Walk (Tekijä), Elizabeth Chenoweth (Tekijä), Ruchika Jain (Tekijä), Itishree Trivedi (Tekijä), Kavitha Santhosh (Tekijä), Vincent B. Young (Tekijä), David M. Aronoff (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: MDPI AG, 2015-09-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

<em>Clostridium difficile</em> infection (CDI) is a significant source of healthcare-associated morbidity and mortality. This study investigated whether serum 25-hydroxyvitamin D is associated with adverse outcomes from CDI. Patients with CDI were prospectively enrolled. Charts were revi...